ProCE Banner Activity

Targeting BCMA in Myeloma: Downloadable Slides

Slideset Download
Downloadable slides with expert analysis of the use of BCMA-targeted therapies for heavily pretreated relapsed/refractory multiple myeloma.

Released: October 26, 2020

Expiration: October 25, 2021

No longer available for credit.

Share

Faculty

Natalie S. Callander

Natalie S. Callander, MD

Professor of Medicine
School of Medicine and Public Health
University of Wisconsin
Director, Myeloma Clinical Program
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Celgene

Faculty Disclosure

Primary Author

Natalie S. Callander, MD

Professor of Medicine
School of Medicine and Public Health
University of Wisconsin
Director, Myeloma Clinical Program
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin

Natalie S. Callander, MD, has disclosed that she has received consulting fees from Cellectar.